Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.

Celene Y L YapDavid McD TaylorJonathan C KnottSimone E TaylorGeorgina A PhillipsJonathan KarroEsther W ChanDavid C M KongDavid J Castle

Published in: Addiction (Abingdon, England) (2017)

A midazolam-droperidol combination appears to provide more rapid sedation of patients with methamphetamine-related acute agitation than droperidol or olanzapine alone.

Keyphrases

liver failure
respiratory failure
aortic dissection
high dose
randomized controlled trial
hepatitis b virus
clinical trial
mechanical ventilation
open label
low dose
combination therapy